Jun. 2 at 9:24 PM
$MGTX I thought people would readily identify the flagship technology I was talking about, namely riboswitch technology for delivery of metabolic peptides. I can see that it wasn't apparent. It would be revolutionary since a oral dosing of something like an activator could adjust the gene therapy dose or pause or terminate the therapy simply by discontinuing the oral dose. Thanks for the suggestion , but I've done my research. I've listened to z a n d y speak and read the conference calls transcripts and I know enough to know that she is too generous in granting herself and her sidekick Company stock-4 million dollars this year.
